Israel · Delayed Price · Currency is ILS · Price in ILA Rekah Pharmaceutical Industry Company Description
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.
The company offers steroids, antibiotics, and ophthalmic products, as well as dermo-cosmetics products.
Its portfolio of products comprise Rx and OTC drugs, and medical devices used in various therapeutic fields, such as urinary tract pain, steroid anti-inflammatories, cough, expectoration and bronchitis, motion sickness, runny nose and congestion, skin disinfection, wounds, burns and insect bites, eye infections, glaucoma, dryness, allergies, fever and pain relief, mouth, depression and anxiety, muscle and joint pain, antibiotics, fungal infections, anemia and nutritional deficits, ear pain, babies and children, etc. Rekah Pharmaceutical Industry Ltd. was founded in 1947 and is based in Holon, Israel.
| Country | Israel |
| Founded | 1947 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 421 |
| CEO | Mordechai Elgrabli |
Contact Details
Address: 30 HAMELACHA ST. Holon, 5881904 Israel | |
| Phone | 972 3 558 1233 |
| Website | rekah.co.il |
Stock Details
| Ticker Symbol | REKA |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| ISIN Number | IL0010810096 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Nir Sella | Chief Executive Officer - Fresh of Life Pharma Ltd. |
| Yaakov Elgrabli | Chief Executive Officer of Ophir and Shalpharm Ltd |
| Mordechai Elgrabli | Chief Executive Officer and Director |
| Georgette Elgrabli | Director of Industrial Division and Director |
| Meir Melumad | Director of Operations |